These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 16633364

  • 1. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.
    Shang Y.
    Nat Rev Cancer; 2006 May; 6(5):360-8. PubMed ID: 16633364
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Extracellular matrix integrity: a possible mechanism for differential clinical effects among selective estrogen receptor modulators and estrogens?
    Cox DA, Helvering LM.
    Mol Cell Endocrinol; 2006 Mar 09; 247(1-2):53-9. PubMed ID: 16426741
    [Abstract] [Full Text] [Related]

  • 5. Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells.
    Flamini MI, Sanchez AM, Goglia L, Tosi V, Genazzani AR, Simoncini T.
    Mol Hum Reprod; 2009 Oct 09; 15(10):675-85. PubMed ID: 19541800
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.
    Nilsson S, Koehler KF.
    Basic Clin Pharmacol Toxicol; 2005 Jan 09; 96(1):15-25. PubMed ID: 15667591
    [Abstract] [Full Text] [Related]

  • 8. Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.
    Georgopoulos NA, Adonakis GL, Fotopoulos A, Koika V, Spinos N, Saltamavros A, Keramopoulos A, Koukouras D, Decavalas G, Kourounis GS.
    Gynecol Endocrinol; 2006 Apr 09; 22(4):185-9. PubMed ID: 16723304
    [Abstract] [Full Text] [Related]

  • 9. Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.
    Vessières A, Top S, Beck W, Hillard E, Jaouen G.
    Dalton Trans; 2006 Jan 28; (4):529-41. PubMed ID: 16402138
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Tamoxifen and endometrial cancer].
    Salamanca-Gómez F.
    Gac Med Mex; 2006 Jan 28; 142(2):171-2. PubMed ID: 16711554
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC, O'Malley BW.
    J Clin Oncol; 2007 Dec 20; 25(36):5815-24. PubMed ID: 17893378
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hormonal therapy for postmenopausal breast cancer: the science of sequencing.
    Miller WR, Bartlett JM, Canney P, Verrill M.
    Breast Cancer Res Treat; 2007 Jun 20; 103(2):149-60. PubMed ID: 17039263
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevention of breast cancer using selective oestrogen receptor modulators (SERMs).
    Powles TJ.
    Breast Cancer Res; 2006 Jun 20; 8(5):111. PubMed ID: 17049068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.